{"product_id":"the-clinical-handbook-of-child-and-adolescent-psychiatry-a-dsm-5-tr-guide-to-diagnosis-evidence-based-treatment-plus-pharmacotherapy-in-pediatric-mental-health","title":"The Clinical Handbook of Child and Adolescent Psychiatry: A DSM 5 TR Guide to Diagnosis, Evidence Based Treatment, plus Pharmacotherapy in Pediatric Mental Health","description":"\u003cdiv\u003e \u003cdiv\u003e \u003cdiv\u003e \u003cspan\u003eThe Diagnostic Edge in Modern Clinical Mycology\u003c\/span\u003e\u003cp\u003e\u003cspan\u003eInvasive fungal infections continue to climb across hospital populations — immunocompromised patients, transplant recipients, neonatal and pediatric wards, and surgical units all face increasing exposure to organisms that look maddeningly similar under the microscope yet demand entirely different therapeutic responses. The cost of misidentification is measured in \u003c\/span\u003e\u003cspan\u003edelayed therapy, inappropriate antifungal selection, prolonged hospitalizations, and patient outcomes that should never have happened\u003c\/span\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis atlas was built for the clinician who needs to \u003c\/span\u003e\u003cspan\u003erecognize the organism in front of them with confidence\u003c\/span\u003e\u003cspan\u003e and act on that recognition without hesitation. Detailed visual references for yeasts, molds, and dimorphic pathogens sit alongside the morphological clues that distinguish them, \u003c\/span\u003e\u003cspan\u003eintegrated with current antifungal selection principles\u003c\/span\u003e\u003cspan\u003e, susceptibility considerations, and clinical decision pathways that translate pathogen recognition into actionable treatment at the bedside.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eWhether you practice clinical microbiology, infectious disease, hematology-oncology, transplant medicine, critical care, or pharmacy advisory services, this reference puts \u003c\/span\u003e\u003cspan\u003epathogen identification and antifungal decision-making in the same place\u003c\/span\u003e\u003cspan\u003e — where they have always belonged but rarely been found together.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eInside this clinical reference:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003e\u003cp\u003e\u003cspan\u003eDetailed morphological identification of medically important \u003c\/span\u003e\u003cspan\u003eyeasts\u003c\/span\u003e\u003cspan\u003e — \u003c\/span\u003e\u003cspan\u003eCandida\u003c\/span\u003e\u003cspan\u003e species, \u003c\/span\u003e\u003cspan\u003eCryptococcus\u003c\/span\u003e\u003cspan\u003e, \u003c\/span\u003e\u003cspan\u003eTrichosporon\u003c\/span\u003e\u003cspan\u003e, \u003c\/span\u003e\u003cspan\u003eRhodotorula\u003c\/span\u003e\u003cspan\u003e, and emerging pathogens including \u003c\/span\u003e\u003cspan\u003eCandida auris\u003c\/span\u003e\u003cspan\u003e — with the distinguishing features that matter at the bench, on chromogenic media, and under microscopy\u003c\/span\u003e\u003c\/p\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003e\u003cp\u003e\u003cspan\u003eVisual recognition of common and uncommon \u003c\/span\u003e\u003cspan\u003emold pathogens\u003c\/span\u003e\u003cspan\u003e — \u003c\/span\u003e\u003cspan\u003eAspergillus\u003c\/span\u003e\u003cspan\u003e species variations, the Mucorales, \u003c\/span\u003e\u003cspan\u003eFusarium\u003c\/span\u003e\u003cspan\u003e, \u003c\/span\u003e\u003cspan\u003eScedosporium\u003c\/span\u003e\u003cspan\u003e, \u003c\/span\u003e\u003cspan\u003eLomentospora\u003c\/span\u003e\u003cspan\u003e, and the dematiaceous molds — with colony morphology, microscopic features, and growth characteristics that drive accurate identification\u003c\/span\u003e\u003c\/p\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003e\u003cp\u003e\u003cspan\u003eComprehensive coverage of \u003c\/span\u003e\u003cspan\u003edimorphic fungal pathogens\u003c\/span\u003e\u003cspan\u003e — \u003c\/span\u003e\u003cspan\u003eHistoplasma\u003c\/span\u003e\u003cspan\u003e, \u003c\/span\u003e\u003cspan\u003eBlastomyces\u003c\/span\u003e\u003cspan\u003e, \u003c\/span\u003e\u003cspan\u003eCoccidioides\u003c\/span\u003e\u003cspan\u003e, \u003c\/span\u003e\u003cspan\u003eParacoccidioides\u003c\/span\u003e\u003cspan\u003e, \u003c\/span\u003e\u003cspan\u003eTalaromyces\u003c\/span\u003e\u003cspan\u003e, and \u003c\/span\u003e\u003cspan\u003eSporothrix\u003c\/span\u003e\u003cspan\u003e — with geographic distribution, clinical presentation patterns, and laboratory hazards that demand specific containment protocols\u003c\/span\u003e\u003c\/p\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003e\u003cp\u003e\u003cspan\u003eCurrent antifungal selection guidance\u003c\/span\u003e\u003cspan\u003e across azoles, echinocandins, polyenes, and emerging agents — including drug-pathogen matching, susceptibility breakpoints, pharmacokinetics, therapeutic drug monitoring, and clinically significant drug-drug interactions\u003c\/span\u003e\u003c\/p\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003e\u003cp\u003e\u003cspan\u003eClinical decision frameworks\u003c\/span\u003e\u003cspan\u003e for empiric versus targeted therapy in invasive candidiasis, invasive aspergillosis, mucormycosis, cryptococcal disease, and endemic mycoses across immunocompetent and immunocompromised hosts\u003c\/span\u003e\u003c\/p\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003e\u003cp\u003e\u003cspan\u003eDiagnostic pathway integration\u003c\/span\u003e\u003cspan\u003e — when to deploy direct microscopy, culture, antigen detection, beta-D-glucan, galactomannan, molecular methods, and histopathology, and how to reconcile discordant results across modalities\u003c\/span\u003e\u003c\/p\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003e\u003cp\u003e\u003cspan\u003eAntifungal stewardship principles\u003c\/span\u003e\u003cspan\u003e, resistance pattern awareness, breakthrough infection management, and dosing adjustments for special populations including pediatric, pregnancy, renal impairment, and hepatic dysfunction integrated throughout\u003c\/span\u003e\u003c\/p\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eBuy Now and arm your clinical practice with the diagnostic precision modern mycology demands.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eEvery fungal diagnostic challenge presents two choices — guess and hope, or recognize and act. This reference exists for clinicians who refuse to leave their patients' outcomes to the first option. Make the second your default.\u003c\/span\u003e\u003c\/p\u003e \u003c\/div\u003e \u003c\/div\u003e \u003c\/div\u003e","brand":"Books Prime","offers":[{"title":"Default Title","offer_id":45913588695231,"sku":"38166379-333f-4e10-aca1-0983b68ba0d6","price":190.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0761\/7550\/7647\/files\/35e3fa3b905c93c15470b1a29a27d28d.jpg?v=1785049098","url":"https:\/\/books-prime.com\/products\/the-clinical-handbook-of-child-and-adolescent-psychiatry-a-dsm-5-tr-guide-to-diagnosis-evidence-based-treatment-plus-pharmacotherapy-in-pediatric-mental-health","provider":"Books Prime","version":"1.0","type":"link"}